Using a similar model involving the 4T1 breast cancer cell line, IL-36γ overexpression promoted Th1 anti-tumorigenic responses, reduced tumour size and reduced the number of metastatic pulmonary lesions. This evidence concerns the gene IL36G and breast carcinoma.